Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z002903 | — |
No additional AE; patient received improperly stored GARDASIL 9; This spontaneous report was received from a nurse and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-Oct-2025, the patient received improperly stored Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), lot #Z002903, expiration date: 15-Dec-2026, 0.5 mL, administered for prophylaxis (route and anatomical site were not reported) (Product storage error). The temperature excursion (TE) was reported as: 4 Hours 30 Minutes @ -7 C. Previous TE: 2 Hours 45 Minutes @ 12.2 C. No additional AE (No adverse event). On 15-Oct-2025, the patient experienced patient received improperly stored GARDASIL 9. On an unknown date, the patient experienced No additional AE. At the reporting time, the outcome of No additional AE and patient received improperly stored GARDASIL 9 was unknown. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant was reported as not applicable.